FIP New GPP Document
FIP New GPP Document
FIP New GPP Document
Eeva Tersalmi MS in Pharm, pharmacy owner FIP Community Pharmacy section, secretary
13.-14.11.2010 1
The reference document accepted in the FIP Council meeting in 2009 The revised FIP/WHO GPP policy guidelines accepted by FIP Council in 2010 The guidelines presented to the 45th WHO Expert Committee on spesifications for Pharmaceutical Preparations
13.-14.11.2010 2
13.-14.11.2010
13.-14.11.2010
Introduction
Health of the public a basic value Poor access to quality medicines and trained health care professionals, high costs Gap between proven efficacy of medicines and their actual effectiveness in practice Patient safety Counterfeiting GPP document describes how pharmacists can improve access to health care, health promotion and the use of medicines on behalf of the patients that they serve
13.-14.11.2010 5
Underlying philosophy
Mission of pharmacy practice is to contribute to health improvement and to help patients with health problems to make the best use of their medicines Readily available, identifying and managing health-related problems, health promotion, assuring effectiveness, preventing harm from medicines, making responsible use of limited health care resources
13.-14.11.2010 6
DEFINITION
GPP is the practice of pharmacy that responds to the needs of the people who use the pharmacists services to provide optimal, evidence based care. To support this practice it is essential that there be an established national framework of quality standards and guidelines
Requirements of GPP
Welfare of patients Make the best use of medicines Promotion of rational and economic prescribing and dispensing Relevant services which are defined and communicated (collaboration) Conditions: National standards for GPP should be spesified and adhered to by practitioners
7 13.-14.11.2010 8
13.-14.11.2010
National level
Legal framework Workforce framework Economic framework
Setting standards
Quality management framework Strategic plan for developing services Needs of users and capacity of national healthcare system to support the servicees Baseline for practice Defining the roles of pharmacists based on needs analysis Functions in these roles, national standards including the activities based on processes Defined and measured by setting indicators of good practice
9 13.-14.11.2010 10
13.-14.11.2010
Role 1, Prepare, obtain, store, secure, distribute, administer and dispose medical products
Prepare extemporaneous drug preparations and medical products Obtain, store and secure drug preparations and medical products Distribute drug preparations and medical products Administration of medicines, vaccines and other injectable medicines Dispose of drug pretarations and medical products
13.-14.11.2010
11
13.-14.11.2010
12
Role 4, contribute to improve effectiveness of the health care system and public health
Disseminate evaluated information about medicines and various aspects of self care Engage in preventive care activities and services Comply with national professional obligations, guidelines and legislations Advocate and support national policies that promote improved health outcomes
13 13.-14.11.2010 14
Plan and implement continuing professional development strategies to improve current and future performance
13.-14.11.2010
Operations need structure to support the work Standardized actions organised in the form of processes We do not know if the structure is right if we do not evaluate it => indicators We do not know how the processes work if we do not measure them => indicators We do not know of outcomes if we do not measure them => indicators
13.-14.11.2010 15
Next step - how to guarantee that Pharmacy practice is Good pharmacy practice
Quality management
Pharmacists and pharmacies have professional responsibilities set by customers and societies To provide services with are reliable, costeffective and which promote right medicine use and patient safety Quality management is the way to manage the work so that these responsibilities are fulfilled. Work is organised in processes to meet the legal requirements, standards and SOPs and based on ethical values, vision and mission.
13.-14.11.2010
16
Weaknesses of pharmacies
The documentation is lacking The practice not based on evidence The effectiveness and efficacy of the services not evaluated The measuring system is weak => Political problems in showing the value of pharmacies in health care. Pharmacies needed for safe practices, adherence, self care support
13.-14.11.2010 17
13.-14.11.2010
18
Donabedian
Structure working environment Processes what is done, all work in pharmacies, based on customer needs Outcomes results of action ECHO-model: economic, clinical, humanistic outcomes
NEED S
Indicators
Direct indicator: the system fulfills the requirement, example: pharmacy is licensed Indirect indicators: pharmacy has sources for information/expectation information is given Due to difficulties to measure final outcomes or their efficacy indirect indicators are sometimes needed. Example public health activities
SATISFACTI ON
13.-14.11.2010 19
13.-14.11.2010
20
13.-14.11.2010
21
13.-14.11.2010
22
13.-14.11.2010
African indicators 2
13.-14.11.2010
25
13.-14.11.2010
26
13.-14.11.2010
27
13.-14.11.2010
Process 1
Process 2
13.-14.11.2010
29
13.-14.11.2010
30
Process 3
Process 4
13.-14.11.2010
31
13.-14.11.2010
32
Process 5
External tools
Customer satisfaction Do I want to recommend this pharmacy? Health professional satisfaction Do we have collaboration which is beneficial? Officials satisfaction Are we ready to pay for the quality?
13.-14.11.2010
33
13.-14.11.2010
34
13.-14.11.2010
35
13.-14.11.2010
36